Compounds > amikacin
Page last updated: 2024-08-23

amikacin and Drug-Induced Cochlear Toxicity

amikacin has been researched along with Drug-Induced Cochlear Toxicity in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (40.00)24.3611
2020's6 (60.00)2.80

Authors

AuthorsStudies
Ayral, M; Dedeoğlu, S1
Endo, A; Hanawa, K; Hanawa, T; Ishikawa, T; Kagami, Y; Katsumata, N; Kawano, Y; Kazama, S; Kobayashi, Y; Maebayashi, Y; Naito, A; Nemoto, A1
Szymański, M; Zadrożniak, M; Łuszczki, JJ1
Camci, ED; Gibson, RM; Kirkwood, NK; Kitcher, SR; Kros, CJ; Raible, DW; Redila, VA; Richardson, GP; Rubel, EW; Simon, JA; Wu, P1
Burt, RA; Lockhart, PJ; Ogier, JM1
Budhathoki, C; Dooley, KE; Dowdy, DW; Farley, JE; Francis, HW; Han, HR; Hong, H1
Fox, GJ; Ho, J; Redwood, L; Velen, K; Wrohan, I1
Brezun, JM; Cazals, Y; Edge, A; Lahlou, H; Lopez-Juarez, A; Ripoll, C; Wang, Q; Zine, A1
Admasu, A; Berha, AB; Negash, Z; Sheth, AN; Shibeshi, W; Yimer, G1
Aznar, ML; Brode, SK; Elshal, AS; Marras, TK; Mehrabi, M1

Reviews

1 review(s) available for amikacin and Drug-Induced Cochlear Toxicity

ArticleYear
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021, 01-01, Volume: 25, Issue:1

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Humans; Ototoxicity; Tuberculosis, Multidrug-Resistant

2021

Other Studies

9 other study(ies) available for amikacin and Drug-Induced Cochlear Toxicity

ArticleYear
Protective effect of ethyl pyruvate on amikacin-induced ototoxicity in rats.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:7

    Topics: Amikacin; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Otoacoustic Emissions, Spontaneous; Ototoxicity; Pyruvates; Rats; Rats, Wistar

2022
Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates.
    Medicine, 2022, Oct-28, Volume: 101, Issue:43

    Topics: Amikacin; Anti-Bacterial Agents; Humans; Infant, Newborn; Kidney; Ototoxicity; Renal Insufficiency

2022
N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease.
    International journal of molecular sciences, 2023, Apr-20, Volume: 24, Issue:8

    Topics: Acetylcysteine; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Auditory Threshold; Deafness; Furosemide; Hearing; Hearing Loss; Mice; Ototoxicity

2023
ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity.
    JCI insight, 2019, 08-08, Volume: 4, Issue:15

    Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Culture Techniques; Cells, Cultured; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Hair Cells, Auditory; Humans; Intravital Microscopy; Ion Channels; Male; Mechanotransduction, Cellular; Mice; Ototoxicity; Patch-Clamp Techniques; Protective Agents; Rats; Thiophenes; Time-Lapse Imaging; Urea; Zebrafish

2019
Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
    Hearing research, 2020, Volume: 386

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Hearing; Hearing Loss; Injections, Intravenous; Kidney; Kidney Diseases; Mice, Inbred C57BL; Ototoxicity; Species Specificity; Time Factors; Tobramycin

2020
Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
    American journal of audiology, 2020, Jun-08, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Audiometry; Auditory Threshold; Cross-Sectional Studies; Female; Hearing Loss; HIV Infections; Humans; Hypoalbuminemia; Kanamycin; Male; Middle Aged; Ototoxicity; Prevalence; Renal Insufficiency; South Africa; Thinness; Tuberculosis, Multidrug-Resistant; Young Adult

2020
Engraftment of Human Stem Cell-Derived Otic Progenitors in the Damaged Cochlea.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2019, 06-05, Volume: 27, Issue:6

    Topics: Amikacin; Animals; Auditory Threshold; Cell Differentiation; Cell Enlargement; Cell Movement; Cyclosporine; Disease Models, Animal; Fibroblast Growth Factor 10; Fibroblast Growth Factor 3; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Humans; Immunosuppressive Agents; Induced Pluripotent Stem Cells; Living Donors; Ototoxicity; Stem Cell Transplantation

2019
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study.
    BMC pharmacology & toxicology, 2019, 05-23, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Creatinine; Ethiopia; Female; HIV Infections; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult

2019
Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada.
    BMC pharmacology & toxicology, 2019, 06-03, Volume: 20, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Ontario; Ototoxicity; Retrospective Studies; Sputum; Treatment Outcome

2019